glp-1-directed nmda receptor antagonism for obesity treatment Targeting GLP-1, GIP & GCG in and Type 2 Diabetes Research Targeting Obesity: GLP-1R, GIPR, GDF8
Pay in 4 interest-free payments of $6.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28






























